Juliane L. Berns

Juliane L. Berns

Auto-generated profile, based on publicly available information

Juliane L. Berns

Institute for Cellular Neurosciences II, Universitätsklinikum Bonn, Bonn, Germany

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2026 in Epilepsia
Verified
Journal Article
Open access
ABAnnika Breuer
Annika Breuer
CHChiara A. Hummel
Chiara A. Hummel
TBTobias Baumgartner
Tobias Baumgartner
JBJuliane L. Berns
Juliane L. Berns
ASAfaf Milad Said
Afaf Milad Said
JPJulika Pitsch
Julika Pitsch
Objective: We investigated the presence and potential functional relevance of antimitochondrial autoantibodies in patients suspicious for autoimmune encephalitis (AIE) associated with psychiatric symptoms and/or seizures, who were negative for known antineuronal autoantibodies. Methods: We screened serum samples from 387 patients autoantibody‐negative for known antineuronal autoantibodies with psychiatric disturbances and/or epileptic seizures, including patients with temporal lobe epilepsy of unknown etiology. Various techniques, including immunoblotting, immunoprecipitation, mass spectrometry, immunohistochemistry, and in vitro assays assessing neuronal autoantibody uptake, neuronal viability, pyruvate dehydrogenase (PDH) enzyme activity, and mitochondrial DNA levels in biofluids were applied. Results: Mass spectrometry detected all three subunits of the intramitochondrial PDHc—pyruvate dehydrogenase, dihydrolipoyl acetyltransferase, and dihydrolipoyl dehydrogenase—as targets of antibodies present in serum samples from three index patients suspicious for AIE with psychiatric symptoms or seizures. The presence of the anti‐PDHc autoantibodies was confirmed by immunoblotting in 12 of 387 patients. Exposure of cultured primary neurons to commercial anti‐PDH antibodies resulted in neuronal uptake and loss of neuronal viability. Patient‐derived autoantibodies also impaired PDH enzyme activity in vitro. Additionally, cell‐free mitochondrial DNA fragment levels were elevated in the serum and cerebrospinal fluid of PDH‐positive patients compared to controls. Significance: Anti‐PDH autoantibodies were detected in patients suspicious for AIE with seizures and/or psychiatric symptoms as core manifestation in the absence of known antineuronal autoantibodies. These autoantibodies bind neuronal structures and reduce PDH enzyme activity under experimental conditions, supporting mechanistic plausibility of a functional role in disease.

4 August 2026 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
YKYulia Kostritskaia
Yulia Kostritskaia
DBDaniela Bulla-Miely
Daniela Bulla-Miely
MEMiriam Engels
Miriam Engels
JMJan Meyer
Jan Meyer
JBJuliane L. Berns
Juliane L. Berns
PKPeter Kovermann
Peter Kovermann
A missense variant in SLC1A3 , which results in a proline to arginine substitution in the glial excitatory amino acid transporter 1 (EAAT1), causes a severe form of episodic ataxia type 6, characterized by recurrent attacks of ataxia and epilepsy. EAATs are dual function transport proteins, and the P290R variant reduces secondary active glutamate transport rates, while enhancing the anion channel activity. Here, we used complementary electrophysiological, imaging, biochemical and neuropathological techniques to characterize the cellular mechanisms underlying epileptic seizures in a mouse model of episodic ataxia type 6, the heterozygous Slc1a3 P290R/+ mouse. Video-EEG recordings demonstrate frequent and severe spontaneous epileptic seizures in vivo. “Gliosis only” phenotype in the cerebrum of Slc1a3 P290R/ + mice, which was restricted to the hippocampal formation, suggests that this brain structure may be involved in the development of epileptic seizure activity. Electrophysiological recordings from acute slices revealed a reduction in tonic GABAergic transmission in Slc1a3 P290R/+ dentate gyrus granule cells, and to a lesser extent in cortical layer 2/3 pyramidal neurons before seizure onset. Phasic GABAergic and glutamatergic transmission remained unaltered in juvenile animals of the same developmental stage. There was no difference in expression levels of the GABA A receptor (GABA A R) δ subunits, suggesting that impaired tonic inhibition results from decreased extrasynaptic GABA concentrations. We identified enhanced GABA uptake by hippocampal radial glia-like cells (RGLs), caused by elevated GABA transporter 3 (GAT-3) expression and by an increased GABA transport driving force—due to lower intracellular chloride levels [Cl – ] int – as cellular basis of impaired tonic inhibition. Our study demonstrates how increased EAAT1 chloride channel activity of the P290R variant can cause hyperexcitability by modifying synaptic GABA concentrations, while impaired EAAT1 glutamate transport leaves glutamatergic synaptic transmission in Slc1a3 P290R/+ mice unaffected.